Ruthie Amir

Ruthie Amir

Chief Tech/Sci/R&D Officer presso SOFWAVE MEDICAL LTD.

58 anni
Health Technology
Finance
Consumer Services

Profilo

Dr. Ruthie Amir joined Alon Medtech Ventures as the chief medical officer in 2018.
Prior to joining Alon Medtech Dr. Amir served as the director of clinical research and the head of the regulatory department of Syneron Candela from 2008 to 2017.
Dr. Ruthie Amir graduated from Ben Gurion University Medical School in 1989.
From 1996-2000, she completed her post-doctoral fellowship in the Department of Human Genetic, at Baylor College of Medicine, Houston, USA where she worked on the genetic basis of Rett Syndrome.
Between 2000-2003 she completed a post-doctoral fellowship in the Department of Cell Biology, Faculty of Medicine, Technion.

Posizioni attive di Ruthie Amir

SocietàPosizioneInizio
SOFWAVE MEDICAL LTD. Chief Tech/Sci/R&D Officer 01/10/2018
EPITOMEE MEDICAL LTD Corporate Officer/Principal 01/05/2018
Corporate Officer/Principal 01/09/2017
Tutte le posizioni attive di Ruthie Amir

Precedenti posizioni note di Ruthie Amir

SocietàPosizioneFine
SYNERON MEDICAL LTD. Chief Tech/Sci/R&D Officer 01/01/2017
Vedi nel dettaglio l'esperienza di Ruthie Amir

Formazione di Ruthie Amir

Medical School For International Health Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Ruthie Amir

Relazioni

53

Relazioni di 1° grado

5

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
EPITOMEE MEDICAL LTD

Health Technology

SOFWAVE MEDICAL LTD.

Health Technology

Aziende private2

Health Technology

Finance

Vedi le connessioni aziendali